Tempus AI (TEM) Price/FCF Ratio: History & Chart

Tempus AI, Inc.(TEM)

Medical - Healthcare Information Services · Chicago, IL

$59.01-2.27 (-3.71%)

Delayed quote: Sep 10, 2026, 3:05 PM EDT

About Tempus AI, Inc.

Tempus AI, Inc. operates as a healthcare technology company in the United States. It offers the Tempus platform, a closed-loop, full-stack, bi-directional integrations between a clinician's desktop and its laboratory diagnostic capabilities, analytics platform, and repository of multimodal data; and Hub, a clinical application for physicians and other healthcare providers for use in the diagnostics product line as an end-to-end application for healthcare providers for NGS tests. The company also provides Lens, a software application for life sciences and advanced precision research; diagnostics services, such as NGS diagnostics, PCR profiling, and other anatomic and molecular pathology tests; and large-panel solid tumor and hematologic testing through multiple assays, with its core clinical assay (xT and xR) offering large panel DNA, RNA full transcriptome, and incidental germline findings through normal blood or saliva analyses. In addition, it provides genetic tests focused on inherited conditions; an nP assay for pharmacogenomic testing for patients with psychiatric conditions, including depression, general anxiety disorder, bipolar disorder, and other relevant diagnoses; Insights, which licenses libraries of linked, de-identified clinical, molecular, and imaging data; Organoids, a tumor derived biological modeling. Further, the company offers Trials for clinical trial matching services; Next, an AI platform; Algos, an algorithm-based diagnostics application. It has Strategic Collaborations with AstraZeneca AB, Pathos AI, Inc., GlaxoSmithKline, Merck, and Recursion Pharmaceuticals, Inc. Additionally, it also has a strategic collaboration with Blood Cancer United to develop registry for pediatric acute myeloid leukemia. The company was formerly known as Tempus Labs, Inc. and changed its name to Tempus AI, Inc. in January 2023. Tempus AI, Inc. was incorporated in 2015 and is headquartered in Chicago, Illinois.

Chicago, IL

3,800 employees

www.tempus.com

Healthcare / Medical - Healthcare Information Services

Sector: Healthcare
Industry: Medical - Healthcare Information Services
CEO: Eric Lefkofsky

View full financials

NAME	MARKET CAP	PRICE/FCF RATIO	TTM	3Y	5Y
Tempus AI, Inc. (TEM)	$10.34B	N/A	N/A	N/A	N/A
Molina Healthcare, Inc. (MOH)vs ›	$10.40B	38.65	35.82	52.04	34.15
Universal Health Services, Inc. (UHS)vs ›	$10.43B	12.62	13.56	16.24	40.38
The Ensign Group, Inc. (ENSG)vs ›	$10.02B	23.91	31.44	33.46	29.44
Bio-Rad Laboratories, Inc. (BIO)vs ›	$9.98B	28.27	23.19	34.37	46.87
Globus Medical, Inc. (GMED)vs ›	$9.95B	13.26	18.99	33.63	37.49
Henry Schein, Inc. (HSIC)vs ›	$9.93B	18.43	21.15	20.37	19.65
Align Technology, Inc. (ALGN)vs ›	$10.78B	19.21	18.63	28.27	38.15
The Cooper Companies, Inc. (COO)vs ›	$10.78B	N/A	30.66	69.52	56.85
Bio-Techne Corporation (TECH)vs ›	$11.31B	42.97	38.99	43.65	47.68

NAME

MARKET CAP

PRICE/FCF RATIO

TTM

Tempus AI, Inc. (TEM)

$10.34B

N/A

Molina Healthcare, Inc. (MOH)vs ›

$10.40B

38.65

35.82

52.04

34.15

Universal Health Services, Inc. (UHS)vs ›

$10.43B

12.62

13.56

16.24

40.38

The Ensign Group, Inc. (ENSG)vs ›

$10.02B

23.91

31.44

33.46

29.44

Bio-Rad Laboratories, Inc. (BIO)vs ›

$9.98B

28.27

23.19

34.37

46.87

Globus Medical, Inc. (GMED)vs ›

$9.95B

13.26

18.99

33.63

37.49

Henry Schein, Inc. (HSIC)vs ›

$9.93B

18.43

21.15

20.37

19.65

Align Technology, Inc. (ALGN)vs ›

$10.78B

19.21

18.63

28.27

38.15

The Cooper Companies, Inc. (COO)vs ›

$10.78B

N/A

30.66

69.52

56.85

Bio-Techne Corporation (TECH)vs ›

$11.31B

42.97

38.99

43.65

47.68

Price/FCF Ratio: N/A

TEM Price/FCF Ratio Metrics

TEM Competitors' Price/FCF Ratio

Free Cash Flow Valuation

Price/FCF Ratio Formula & Definition

Related Metrics